Description générale
Atazanavir+ritonavir is a combination used in the treatment of HIV/AIDS. Although they were initially developed as independent antiviral agents, they have been shown to possess advantageous properties in combination regimens.
INN
Atazanavir + ritonavir
Codes ATC
Type de médicament
Diagnostic agent
Historique des statuts LME
Ajouté pour la première fois en 2017
(TRS
1006)
pour
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified
Wikipédia
DrugBank
Recommandations
Section
Antiretrovirals > Protease inhibitors
- Oral > Solid: 300 mg (as sulfate) + 100 mg tablet (heat stable)